| |
|
|
|
|
|
|
|||
|
CR Zerez, MD Wong and KR Tanaka
Department of Medicine, Harbor-UCLA Medical Center, Torrance 90502.
We have examined properties of nicotinamide adenine dinucleotide (NAD)
synthetase from human erythrocytes. The enzyme was found to be cold labile
and extremely unstable in crude hemolysate, with complete loss of activity
occurring after 24 hours at 4 degrees C. However, maintenance of crude
hemolysate at 20 to 25 degrees C in the presence of EDTA and KCl increased
NAD synthetase stability substantially (half- life = 10 days). Using these
conditions, NAD synthetase was purified 3,100-fold with a 29% yield using
DEAE-cellulose column chromatography, ammonium sulfate fractionation, and
dialysis. The apparent Michaelis- Menten constants for nicotinic acid
adenine dinucleotide (NAAD), adenosine triphosphate, Mg2+, glutamine, and
K+ were 0.108, 0.154, 1.36, 2.17, and 8.32 mmol/L, respectively. The pH
optimum ranged between 6.8 and 7.4, and the molecular weight was estimated
to be 483 +/- 5 Kd. The enzyme was markedly inhibited by Pb2+ and Zn2+,
with concentrations necessary for 50% inhibition of activity of 1.3 and 2.0
mumol/L, respectively. The incubation of intact red blood cells with lead
followed by rigorous washing to remove lead abolished nearly all NAD
synthetase activity. In contrast, glucose-6-phosphate dehydrogenase
activity, which is not sensitive to lead, was unaffected, whereas
pyrimidine 5'-nucleotidase activity, which is sensitive to lead, was
decreased 30% to 50% under these conditions. More importantly, patients
with lead overburden (34 to 72 micrograms Pb2+/dL blood) all had markedly
decreased NAD synthetase activity. These data together with other results
suggest that erythrocyte NAD synthetase activity is a sensitive indicator
of lead exposure in humans.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1990 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||